What Is A Zoonotic Disease Understanding Key Factors And Global Impacts

Published

Table of Contents

Zoonotic diseases represent a critical intersection of animal and human health, where pathogens originating in wildlife or domesticated species cross species barriers to infect humans. These infections account for over 60% of emerging human diseases, posing persistent challenges to global health security. From the 1918 Spanish Flu to the ongoing COVID-19 pandemic, zoonoses have repeatedly reshaped epidemiology, economies, and public policy. Understanding their biological mechanisms, transmission pathways, and ecological drivers is essential to mitigating future outbreaks.

The distinction between zoonotic diseases and other infectious agents lies in their bidirectional or unidirectional transmission dynamics, reservoir hosts, and adaptive potential. For instance, while rabies primarily transmits from animals to humans, influenza A exhibits bidirectional spillover, complicating containment efforts. Reservoir hosts—such as bats for Nipah virus or rodents for hantavirus—often sustain pathogens without clinical symptoms, creating silent reservoirs for human exposure. Additionally, pathogens vary in zoonotic potential, from highly adaptive viruses like H5N1 to more stable parasites like Toxoplasma gondii, each presenting unique risks.

what is a zoonotic disease

Definition and Core Characteristics of Zoonotic Diseases

Zoonotic diseases represent a critical intersection between animal and human health, accounting for approximately 60% of all emerging infectious diseases and 75% of new or re-emerging pathogens since 1940. Unlike anthroponoses (human-specific infections like measles or HIV) or sapronoses (environmental pathogens such as Cryptococcus neoformans), zoonoses originate in vertebrate animals and can transmit to humans under natural conditions. Their classification hinges on three foundational biological and epidemiological criteria: transmission directionality, reservoir host specificity, and adaptive potential within human populations. These features distinguish zoonoses from other infectious disease categories by emphasizing their interspecies transmission dynamics and ecological dependencies.

The core distinction between zoonotic diseases and other pathogens lies in their dual-host systems, where animals serve as either primary reservoirs or incidental hosts. While anthroponoses are strictly human-adapted, zoonoses exhibit unidirectional or bidirectional spillover, with some pathogens (e.g., Yersinia pestis) maintaining high circulation in wildlife while others (e.g., Influenza A) demonstrate reversible adaptation between species. The following structured breakdown outlines the defining features of zoonotic pathogens, supported by epidemiological evidence and case studies.

Transmission Directionality and Pathways

Zoonotic transmission occurs via direct contact (e.g., bites, scratches, mucosal exposure) or indirect routes (vector-borne, airborne, or fomite-mediated). The directionality—whether animal-to-human (zoonotic spillover) or human-to-animal (anthropozoonosis)—determines outbreak patterns and control strategies. Below is a transmission pathway flowchart (described textually for clarity) illustrating the primary routes:

1. Direct Transmission

  • Animal-to-human: Physical contact with infected animals (e.g., Bacillus anthracis via livestock handling, Leptospira through urine exposure).
  • Zoonotic spillover events: Rare but high-impact (e.g., Nipah virus from bat saliva, Ebola from fruit bat reservoirs).
  • Human-to-animal: Reverse transmission (e.g., MRSA in livestock from human farmers, avian influenza H5N1 in wild birds from poultry).

    • 2. Indirect Transmission

  • Vector-borne: Arthropod vectors (e.g., Plasmodium via Anopheles mosquitoes for malaria, Rickettsia rickettsii via ticks for Rocky Mountain spotted fever).
  • Environmental reservoirs: Contaminated water/soil (e.g., Leptospira in rice paddies, Cryptosporidium in recreational water).
  • Fomite-mediated: Inanimate objects (e.g., Salmonella on undercooked poultry, Coxiella burnetii in dust from infected livestock).

    • Key Insight:

    Zoonotic pathogens exploit ecological niches in animal hosts, with transmission efficiency varying by species behavior (e.g., bats’ high viral loads vs. rodents’ burrowing habits). Spillover risk increases in anthropogenic settings (deforestation, urbanization), where wildlife-human interfaces expand.

    Reservoir Hosts and Maintenance Cycles

    The reservoir host is the primary species or population sustaining the pathogen without apparent disease, enabling long-term circulation. Reservoirs can be wildlife (e.g., bats for Marburg virus), domestic animals (e.g., chickens for avian influenza), or livestock (e.g., cattle for brucellosis). The maintenance cycle—how the pathogen persists—varies by host ecology:

    - Enzootic maintenance: Pathogen circulates endemically in wildlife (e.g., hantaviruses in rodents, lymphocytic choriomeningitis virus in house mice).

  • Epizootic outbreaks: Periodic surges in animal populations (e.g., rabies in raccoons during population booms).
  • Anthropozoonotic feedback: Human activities amplify transmission (e.g., swine influenza from pig farming intensification).

    • Critical Reservoir Examples:

    td>Pteropodid bats (Pteropus spp.)
    Pathogen Reservoir Host Transmission Mechanism Human Disease
    Hantavirus (e.g., Sin Nombre) Peromyscus rodents (deer mice) Aerosolized urine/feces in contaminated environments Hantavirus pulmonary syndrome (HPS)
    Nipah virus Saliva, urine, or fruit contamination Encephalitis with high case-fatality rate (40–75%)
    Brucella spp. Cattle, goats, swine Unpasteurized dairy, direct contact with aborted fetuses Brucellosis (undulant fever)
    Plasmodium falciparum Anopheles mosquitoes Vector-borne blood transmission Malaria (500,000+ annual deaths)
    Reservoir Dynamics:
    Spillover-prone reservoirs share traits: (1) high pathogen loads (e.g., bats’ immune tolerance to lyssaviruses), (2) behavioral synergy with humans (e.g., rodents in agricultural fields), and (3) ecological disturbance sensitivity (e.g., deforestation exposing bats to human settlements).

    Zoonotic Potential and Adaptive Traits

    Not all animal pathogens pose equal zoonotic risk. Zoonotic potential reflects a pathogen’s ability to:
    1. Cross species barriers (e.g., HIV-1 from chimpanzees via SIV recombination).
    2. Establish human-to-human transmission (e.g., SARS-CoV-2 from bats via intermediate hosts).
    3. Evade host immune responses (e.g., Toxoplasma gondii’s chronic latency in humans).

    Key Adaptive Mechanisms:

  • Genetic plasticity: Reassortment (influenza A), recombination (HIV), or mutation (Ebola).
  • Host range expansion: Influenza A H5N1’s adaptation to poultry and limited human cases vs. SARS-CoV’s efficient human transmission.
  • Environmental persistence: Prions (e.g., TSEs in cattle) resist inactivation, enabling indirect transmission.

    • Risk Stratification by Potential:

    Zoonotic Potential Category Examples Human Adaptation Status Outbreak Risk
    High Influenza A (H5N1, H7N9), Ebola virus, Nipah virus Limited human-to-human transmission (except H5N1 in rare clusters) Severe, sporadic outbreaks with pandemic potential
    Moderate Salmonella spp., Leptospira, Rickettsia Occasional human adaptation (e.g., Salmonella Typhi in typhoid) Endemic with localized epidemics
    Low Toxoplasma gondii, Taenia solium, Borrelia burgdorferi Chronic infections without sustained transmission Low outbreak risk; high individual morbidity
    Evolutionary Insight:
    Pathogens with broad host ranges (e.g., Leptospira interrogans infecting >150 mammal species) exhibit higher zoonotic potential due to pre-adapted genetic flexibility. Conversely, specialized parasites (e.g., Plasmodium falciparum in Anopheles) rely on complex transmission cycles, reducing spillover frequency but increasing impact when it occurs.

    what is a zoonotic disease - Ilustrasi 2

    Notable Examples and Case Studies of Zoonotic Diseases

    Zoonotic diseases have repeatedly reshaped human history, with some outbreaks causing unprecedented global disruptions. These case studies illustrate the complex interplay between animal reservoirs, intermediate hosts, and human transmission pathways, as well as the varying scales of impact—from acute pandemics to chronic, debilitating conditions. Below are three historically significant zoonotic diseases, analyzed for their epidemiological origins, transmission mechanics, and societal consequences, followed by a comparative assessment of their global health burdens.

    1918 Spanish Flu (H1N1 Avian Origin)

    The 1918 influenza pandemic, caused by an H1N1 strain with avian origins, remains the deadliest recorded outbreak in modern history, infecting an estimated 500 million people and killing 50–100 million, with mortality rates exceeding 2.5% of the global population. Genetic and phylogenetic evidence confirms the virus’s avian ancestry, though its exact zoonotic spillover pathway remains debated. The timeline of spillover events suggests a multi-host adaptation process, likely involving:
  • Initial avian reservoir: Wild birds (e.g., waterfowl) harbored ancestral strains of H1N1 with low human infectivity.
  • Intermediate host adaptation: Pigs, known as "mixing vessels" for influenza viruses due to their dual receptor binding (avian and mammalian), facilitated reassortment of viral segments, enhancing human transmissibility.
  • Human spillover: The virus likely jumped to humans via pig-to-human transmission in late 1917 or early 1918, followed by rapid global dissemination through troop movements during World War I.

    • Key epidemiological features:

  • Wave patterns: Three distinct waves (Spring 1918, Autumn 1918, and Winter 1919) with the second wave exhibiting hypervirulence, particularly among young adults (20–40 years old), possibly due to a cytokine storm response.
  • Secondary transmission: Human-to-human spread occurred via respiratory droplets, with a basic reproduction number (R₀) of 1.8–2.0, higher than seasonal flu strains.
  • Genetic mutations: The 1918 strain’s hemagglutinin (HA) and neuraminidase (NA) proteins exhibited adaptations for mammalian hosts, including glycan-binding preferences favoring human upper respiratory tract receptors.

    • Legacy:
    The pandemic’s severity was exacerbated by co-infections with bacterial pneumonia (e.g., Streptococcus pneumoniae) and poor public health infrastructure. Modern surveillance systems now prioritize avian influenza monitoring (e.g., H5N1, H7N9) to prevent similar spillovers, though the 1918 strain’s exact avian progenitor remains unidentified due to genetic divergence over a century.

    Bovine Spongiform Encephalopathy (BSE) and Variant Creutzfeldt-Jakob Disease (vCJD)

    Bovine Spongiform Encephalopathy (BSE), or "mad cow disease," emerged in the UK in 1986 as a prion-mediated zoonotic disease, later linked to variant Creutzfeldt-Jakob Disease (vCJD) in humans. Unlike viral zoonoses, BSE demonstrates prion transmission—a rare mechanism where misfolded proteins (prions) induce abnormal folding in host proteins, leading to neurodegenerative disease. The outbreak underscores the risks of cross-species prion transmission through dietary exposure.

    Transmission pathway and prion mechanics:

  • Animal reservoir: BSE originated from feed contaminated with sheep scrapie prions, a practice banned in the 1980s after the link was established. Cattle consumed rendered meat-and-bone meal from infected sheep, initiating the BSE epidemic.
  • Prion adaptation: The BSE prion strain (BSE agent) exhibited species-barrier crossing, infecting cattle despite their natural resistance to scrapie prions. Key adaptations included:
  • Conformational changes in the prion protein (PrP), allowing it to replicate efficiently in bovine brains.
  • Strain-specific glycosylation patterns, distinguishing BSE prions from sheep scrapie.
  • Human transmission (vCJD): Consumption of BSE-contaminated beef led to vCJD, a rare but 100% fatal prion disease. The incubation period ranged from 10 to 40 years, with symptoms including psychiatric changes, dementia, and motor dysfunction.

    • Epidemiological impact:

  • Cattle cases: Over 180,000 BSE cases were reported globally, primarily in the UK, with slaughter and feed bans implemented to curb spread.
  • Human cases: As of 2023, 231 confirmed vCJD cases worldwide, with 178 in the UK. The case fatality rate (CFR) is 100%, though secondary transmission (e.g., blood transfusions) remains rare.
  • Public health response: The outbreak led to global bans on mammalian-derived feed, prion detection assays (e.g., rapid tests for BSE in cattle), and surveillance for atypical prion diseases (e.g., CWD in deer).

    • Prion transmission mechanics:

    Prions propagate via a template-assisted misfolding mechanism, where the abnormal prion protein (PrP^Sc) converts the host’s normal prion protein (PrP^C) into a beta-sheet-rich aggregate. Unlike viruses, prions lack nucleic acid; their infectivity relies solely on protein conformation. In vCJD, the BSE prion strain exhibits a distinct molecular signature (e.g., type 1/2B prion protein) detectable via Western blot or PMCA (Protein Misfolding Cyclic Amplification).
    Lessons learned:
    The BSE-vCJD crisis revealed vulnerabilities in food safety regulations and the unpredictability of prion zoonoses. Current measures include:
  • Feed restrictions: EU-wide ban on ruminant-derived feed for cattle.
  • Surveillance: Mandatory brainstem testing in slaughtered cattle.
  • Research: Studies on cross-species prion transmission risks (e.g., chronic wasting disease in cervids).

    • COVID-19 Pandemic: Zoonotic Origins and Viral Adaptation

    The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), responsible for the COVID-19 pandemic (2019–2020), originated from a zoonotic spillover event with complex intermediate host dynamics. Genetic and epidemiological evidence supports a multi-host transmission pathway, culminating in human adaptation via receptor binding optimization.

    Intermediate host hypothesis: Bats → Pangolins → Humans

  • Primary reservoir: Rhinolophus bats (horseshoe bats) in Yunnan Province, China, harbor bat coronaviruses (e.g., RaTG13) with ~96% genome identity to SARS-CoV-2. However, key mutations in the receptor-binding domain (RBD) distinguish SARS-CoV-2, suggesting recombination or intermediate adaptation.
  • Intermediate host (pangolins): Malayan pangolins (Manis javanica) in southern China were found with coronaviruses (e.g., Pangolin-CoV) sharing 91–92% genome similarity to SARS-CoV-2, particularly in the RBD region. This supports a pangolin-mediated adaptation hypothesis, where the virus acquired human ACE2-binding affinity before spillover.
  • Human spillover: The index case (Patient Zero) remains unidentified, but Huanan Seafood Market in Wuhan served as an amplification hub, with early cases linked to wild animal trade. Phylogenetic analysis suggests multiple zoonotic introductions, not a single spillover event.

    • Genetic evidence of human ACE2 adaptation
    SARS-CoV-2’s spike protein underwent critical mutations enhancing binding to the human angiotensin-converting enzyme 2 (ACE2) receptor, a prerequisite for efficient human transmission:

  • Key mutations in the RBD:
  • Leucine (L) to Valine (V) at position 367 (L367V) – Increases ACE2 affinity.
  • Alanine (A) to Serine (S) at position 477 (A477S) – Enhances receptor binding.
  • Aspartic acid (D) to Glycine (G) at position 614 (D614G) – Associated with higher transmissibility (dominant variant in 2020).
  • Structural adaptations:
  • The RBD adopts an "up" conformation in SARS-CoV-2, unlike

    • what is a zoonotic disease - Ilustrasi 3

    Mechanisms of Transmission and Pathogen Adaptation in Zoonotic Diseases

    Zoonotic diseases emerge through complex interactions between pathogens, animal reservoirs, and environmental pressures. Molecular adaptations in pathogens—such as genetic reassortment, antigenic variation, or enhanced transmissibility—facilitate spillover into human populations. Concurrently, ecological disruptions, including land-use changes and climate variability, expand opportunities for pathogen exposure by altering host distributions, vector habitats, and transmission dynamics. Understanding these mechanisms is critical for predicting emergence risks and designing targeted interventions.

    Pathogen adaptation and spillover are driven by evolutionary pressures that enhance survival, replication, and cross-species transmission. RNA viruses, bacteria, and parasites exhibit distinct strategies to overcome host barriers, exploit new niches, and persist in diverse environments. Below, the molecular and ecological factors enabling zoonotic spillover are examined, alongside the role of anthropogenic drivers in amplifying transmission risks.

    Antigenic Drift and Shift in RNA Viruses

    RNA viruses, particularly those with segmented genomes (e.g., influenza A viruses) or high mutation rates (e.g., coronaviruses), undergo antigenic drift (gradual mutations) and antigenic shift (sudden reassortment of gene segments) to evade host immune responses. These processes are central to zoonotic spillover, as they allow pathogens to adapt to new hosts while maintaining infectivity.

    Influenza A Virus (Orthomyxoviridae):
    The hemagglutinin (HA) and neuraminidase (NA) surface glycoproteins undergo frequent mutations in their receptor-binding domains (RBDs). For example, avian influenza viruses (e.g., H5N1) bind preferentially to α2,3-linked sialic acids in avian respiratory tracts, while human-adapted strains (e.g., H1N1) bind α2,6-linked sialic acids in human upper respiratory epithelia. Reassortment between avian and human strains in intermediate hosts (e.g., pigs) can generate hybrid viruses with enhanced human transmissibility.
    > Key Mutation Sites:
    > - HA1 subunit (positions 190, 225, 226, 228): Critical for host specificity.
    > - NA stalk region: Influences viral release efficiency in human cells.

    Coronaviruses (e.g., SARS-CoV, MERS-CoV, SARS-CoV-2):
    The spike (S) protein RBD undergoes mutations that alter affinity for the angiotensin-converting enzyme 2 (ACE2) receptor, the primary human entry point. For instance:

  • SARS-CoV-2: The D614G mutation in the S protein increased infectivity by stabilizing the open conformation of the RBD.
  • MERS-CoV: Binds dipeptidyl peptidase 4 (DPP4), with camel-to-human spillover facilitated by S protein mutations (e.g., T478K) enhancing receptor affinity.

    • Diagram Description (Receptor-Binding Domain Mutations):
    A schematic of the HA or S protein RBD would illustrate:
    1. Wild-type avian strain: High affinity for α2,3-sialic acid (blue receptor).
    2. Reassorted human-adapted strain: Altered RBD conformation (e.g., Q226L mutation) shifting preference to α2,6-sialic acid (red receptor).
    3. Coronavirus S protein: Pre- and post-mutation RBD structures with ACE2 binding sites highlighted, showing how N501Y (SARS-CoV-2) or S375F (MERS-CoV) mutations enhance human tropism.

    Bacterial Biofilm Formation and Persistence in Animal Reservoirs

    Bacteria such as Salmonella, Campylobacter, and Escherichia coli O157:H7 form biofilms—structured microbial communities encased in extracellular polymeric substances (EPS)—that enhance survival in animal hosts and environmental reservoirs. Biofilms confer resistance to antibiotics, disinfectants, and host immune clearance, facilitating prolonged shedding and zoonotic transmission.

    Mechanisms of Biofilm-Mediated Persistence:

  • Adhesion and colonization: Bacterial fimbriae (e.g., type I pili in E. coli) and curli fibers (in Salmonella) bind to intestinal epithelial cells or abiotic surfaces (e.g., poultry processing equipment).
  • EPS matrix composition: Composed of polysaccharides (e.g., cellulose, alginate), proteins (e.g., biofilm-associated protein, Bap), and extracellular DNA (eDNA), which protect against desiccation and antimicrobials.
  • Quorum sensing: Bacteria coordinate biofilm formation via acyl-homoserine lactone (AHL) signaling (e.g., in Salmonella enterica), synchronizing gene expression for virulence and persistence.

    • Examples:

  • Salmonella enterica in poultry: Biofilms in cecal contents and processing plant surfaces enable chronic colonization, with ~20% of asymptomatic carrier hens shedding bacteria for months. Mutations in rpoS (stress response regulator) and csgD (curli biosynthesis) enhance biofilm stability.
  • Mycobacterium bovis in cattle: Forms granuloma-like biofilms in lymph nodes, evading immune clearance and enabling latent tuberculosis transmission to humans via unpasteurized milk.

    • Environmental Transmission Routes:

  • Fecal-oral: Biofilm-embedded bacteria in manure contaminate water or produce (e.g., E. coli O157:H7 in spinach).
  • Aerosolization: Processing dust (e.g., poultry slaughterhouses) disperses biofilm fragments containing viable cells.
  • Vector-borne: Ticks (Borrelia burgdorferi) or flies (Salmonella in poultry litter) mechanically transmit biofilm-associated pathogens.

    • Parasitic Life Cycles and Environmental Contamination

    Parasites exhibit complex life cycles involving multiple hosts and environmental stages, often relying on free-living stages (e.g., oocysts, cysts) for transmission. Disruptions in these cycles—such as defecation in urban areas or waterborne contamination—amplify zoonotic risks. Three key examples illustrate these pathways:

    1. Toxoplasma gondii:

  • Definitive host (felids): Cats shed unsporulated oocysts in feces, which sporulate in 1–5 days under moist, shaded conditions.
  • Environmental persistence: Oocysts survive for months to years in soil, water, or vegetation, contaminating produce (e.g., leafy greens) or soil (e.g., gardening).
  • Intermediate hosts: Humans and livestock ingest sporulated oocysts via fecal-oral routes or undercooked meat (bradyzoites in muscle tissue).

    • 2. Echinococcus granulosus:

  • Canid definitive hosts (e.g., dogs): Shed proglottids containing eggs in feces.
  • Environmental stage: Eggs contaminate pastures or water, infecting livestock (sheep, cattle) or humans via ingestion.
  • Human cystic echinococcosis: Larval stages form hydatid cysts in organs, with ~1 million cases globally, primarily in pastoral regions (e.g., Argentina, Turkey).

    • 3. Cryptosporidium parvum:

  • Oocyst shedding: Cattle and other ruminants excrete ~10^6–10^8 oocysts/day, resistant to chlorination.
  • Waterborne outbreaks: Contaminated surface water or recreational lakes (e.g., Milwaukee, 1993 outbreak: 403,000 cases) cause self-limiting but severe diarrhea in immunocompromised individuals.

    • Environmental Stability Factors:

  • Oocyst resilience: Toxoplasma and Cryptosporidium oocysts survive UV radiation, freezing, and desiccation due to calcium-dependent proteins and thick walls.
  • Temperature-dependent sporulation: Toxoplasma oocysts require 18–30°C and humidity; drought or flooding can concentrate oocysts in water sources.

    • Climate Change and Land-Use Alterations Expanding Zoonotic Risks

    Anthropogenic changes—deforestation, wetland drainage, and temperature shifts—disrupt ecosystems, increasing pathogen-host-vector interactions. These alterations expand geographic ranges of reservoirs, prolong transmission seasons, and create novel spillover opportunities.

    1. Deforestation and Emerging Zoonoses:

  • Ebola virus (Filoviridae): Linked to bushmeat hunting and habitat fragmentation in Central Africa. Deforestation increases human-wildlife contact (e.g., fruit bats as reservoirs) and rodent population density, amplifying spillover.
    • > Deforestation Hotspots and Associated Diseases:
    >

    Zoonotic diseases underscore the intricate relationships between ecosystems, wildlife, and human populations, where ecological disruptions—such as deforestation, climate change, and urbanization—accelerate pathogen spillover. The 2019 COVID-19 pandemic, for example, highlighted how intermediate hosts and receptor adaptations enable cross-species transmission, while case studies like BSE and Ebola demonstrate the devastating consequences of prion diseases and high-fatality viruses. Addressing these challenges requires a multidisciplinary approach, integrating veterinary science, epidemiology, and environmental policy to disrupt transmission cycles before they escalate into global crises.

    FAQ

    Can you give an example of a zoonotic disease?

    A zoonotic disease example is rabies, which spreads from animals like bats or raccoons to humans through bites or scratches. Others include salmonellosis (from contaminated food or pets) and Lyme disease (transmitted by ticks from deer or rodents).

    What is the definition of a zoonotic disease?

    A zoonotic disease is an infectious disease that naturally transmits between vertebrate animals and humans. These diseases can jump from animals (wild or domestic) to people, often through direct contact, vectors like mosquitoes, or contaminated food/water.

    How do zoonotic diseases affect animals?

    Zoonotic diseases can cause illness, death, or long-term health issues in animals just as they do in humans. For example, avian flu harms poultry, while bovine spongiform encephalopathy (BSE) devastates cattle populations. Animals may also act as silent carriers, spreading the disease without showing symptoms.

    Which zoonotic diseases can dogs carry?

    Dogs can transmit rabies (through bites), leptospirosis (via urine-contaminated water), and campylobacteriosis (from fecal exposure). Toxocariasis (roundworm) is another risk, especially for children playing near dog feces.

    What is a zoonosis disease?

    A zoonosis disease (or zoonotic disease) is any infection that originates in animals but can infect humans, such as Ebola (from bats), West Nile virus (mosquitoes), or toxic shock syndrome (from animal-derived bacteria). The term "zoonosis" refers to the natural transmission cycle between species.

    What are some diseases that are not zoonotic?

    Non-zoonotic diseases do not involve animal reservoirs and include influenza A (H1N1) (primarily human-to-human), measles, HIV/AIDS, and COVID-19 (though some coronaviruses like SARS-CoV-1 were zoonotic). Fungal infections like athlete’s foot (from soil/fomites) are also non-zoonotic.